[
serum institute of india
]PAGE 3
Latest from serum institute of india
SII to develop Mpox vaccine within a year
Serum Institute of India (SII) Pune on Tuesday said it is currently working to develop a vaccine for Mpox with positive outcomes expected in a year’s time
Updated on Aug 21, 2024 08:00 AM IST
Vicky Pathare
Pune’s Serum Institute ships malaria vaccine to African countries
Serum Institute of India ships R21/Matrix-M™ malaria vaccine to Africa, starting with Central African Republic. 163,800 doses allocated for CAR.
Updated on May 21, 2024 07:36 AM IST
Vicky Pathare
SII to acquire 20% stake in needle-free tech firm IntegriMedical
Vaccine major SII on Friday announced to acquire 20 per cent stake in medical device company IntegriMedical to advance in needle-free injection system technology
Updated on May 18, 2024 08:18 AM IST
All Covishield side-effects were disclosed: Serum Institute of India
Emphasizing safety as a priority, the company also highlighted Covishield’s role in saving millions of lives globally.
Updated on May 09, 2024 04:10 AM IST
Vicky Pathare
Parents sue Serum Institute over daughter's death, allegedly due to Covishield
Covishield is the Indian variant of AstraZeneca's Covid-19 vaccine. AstraZeneca recently admitted that its vaccine can cause a rare side-effect called ‘TTS.’
Published on May 02, 2024 11:19 AM IST
HT News Desk, New Delhi
9
